tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Advanced Medical Solutions Announces Total Voting Rights Update

Story Highlights
Advanced Medical Solutions Announces Total Voting Rights Update

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Advanced Medical Solutions ( (GB:AMS) ) has issued an announcement.

Advanced Medical Solutions Group plc announced its total issued share capital as of August 29, 2025, comprising 219,330,534 ordinary shares, each with voting rights, with no shares held in treasury. This information is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure and Transparency Rules, impacting how they manage their interests in the company.

The most recent analyst rating on (GB:AMS) stock is a Hold with a £219.00 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.

Spark’s Take on GB:AMS Stock

According to Spark, TipRanks’ AI Analyst, GB:AMS is a Neutral.

Advanced Medical Solutions demonstrates strong revenue growth and a solid capital structure, which are significant strengths. However, the high P/E ratio suggests potential overvaluation, and declining profitability margins indicate operational challenges. Technical indicators show a neutral trend with potential for upward momentum.

To see Spark’s full report on GB:AMS stock, click here.

More about Advanced Medical Solutions

Advanced Medical Solutions Group plc (AMS) is a leading independent developer and manufacturer of innovative tissue-healing technologies, focusing on quality outcomes for patients and value for payers. The company offers a wide range of surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants, marketed under various brands such as LiquiBand®, RESORBA®, and others. AMS also provides wound care dressings through its ActivHeal® brand and white label products. Since 2019, AMS has expanded through multiple acquisitions, enhancing its portfolio in surgical biomaterials and wound care solutions. The company operates globally with manufacturing and R&D hubs across several countries and employs over 1,600 people.

Average Trading Volume: 495,900

Technical Sentiment Signal: Sell

Current Market Cap: £437M

For detailed information about AMS stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1